PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 83 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $340,000 | +83.8% | 33,664 | +90.2% | 0.10% | +222.6% |
| Q2 2020 | $185,000 | -87.0% | 17,700 | -89.1% | 0.03% | -76.7% |
| Q4 2019 | $1,419,000 | -58.4% | 162,141 | -48.8% | 0.13% | -54.8% |
| Q3 2019 | $3,407,000 | +1.9% | 316,474 | +20.4% | 0.29% | +12.2% |
| Q2 2019 | $3,342,000 | -16.0% | 262,945 | +34.4% | 0.26% | -15.5% |
| Q4 2018 | $3,980,000 | +430.7% | 195,589 | +2178.0% | 0.31% | +463.6% |
| Q2 2017 | $750,000 | -93.6% | 8,586 | -97.8% | 0.06% | -93.3% |
| Q2 2016 | $11,789,000 | +149.2% | 395,750 | +145.7% | 0.82% | +158.5% |
| Q1 2016 | $4,730,000 | -13.7% | 161,078 | +30.5% | 0.32% | -52.8% |
| Q2 2013 | $5,478,000 | – | 123,473 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
| Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
| PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
| TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
| Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
| Leap Investments LP | 29,100 | $370,000 | 0.50% |
| Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
| Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
| Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |